Data & Analytics
Identify, Segment, and
Target the Right HCPs
Find and reach more providers with the right data foundation.
30%
of KOLs have no recorded interactions with MSLs
#1
hurdle to scaling digital and analytics in healthcare is fragmented data
81 %
of pharmas have moderate to no visibility into HCP/HCO relationships
Sources: Veeva Pulse, Avalere
The State of Data, Analytics, and AI in Commercial Biopharma
Accelerate commercial AI and analytics adoption at scale
“When you have clean, fast data, you can have better analytics. This is how we are driving more precision engagement.”
Elodie Privat
Sales Analytics and Operations Lead, Novartis Gene Therapies
“Veeva brings a deep expertise and a unique set of data assets that really give us an incredibly strong analytical foundation to understand our HCPs and our customers.”
Eric Solis
Director, Lead Data Scientist, Takeda
“The expectations and the landscape of the pharma industry are shifting. When you think about speed and agility, data is the fuel to help your business accelerate.”
Sopheara Peoples
Senior Director, Head of Oncology Digital Data and Technology, GSK
Tips & Insights
How biopharma leaders identify
and prioritize KOLs and HCPs
HCP segmentation and targeting solutions
Prioritize the right HCPs with connected customer, patient, prescriber, and KOL data.